VSEE VSEE HEALTH, INC.
Services-Health Services · OTC · SEC CIK 1864531 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.4%
TTM net income YoY81.1%
TTM EPS YoY96.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin39.8%
Operating margin-99.7%
Net margin-113.8%
FCF margin-58.5%
EBITDA margin-76.1%
Returns
ROE-1,345.0%
ROA-71.5%
ROIC (approx.)-403.4%
Asset turnover0.63x
Leverage & solvency
Liabilities / assets54.6%
Debt / equity0.15x
Current ratio0.40x
Interest coverage-5.60x
Cash quality & payout
Operating cash flow / net income0.51x
Accruals ratio-35.4%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q2*2026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $1.50M | $1.56M | $3.16M | $3.93M | $2.32M | $1.06M | $3.32M | $3.86M |
| Cost of revenue | $1.19M | $1.36M | $1.96M | $2.09M | $1.19M | $440,147 | $1.46M | $1.43M |
| Gross profit | $310,679 | $206,153 | $1.20M | $1.83M | $1.13M | $615,044 | $1.86M | $2.43M |
| SG&A expense | $2.03M | $2.25M | $2.44M | $2.92M | $2.54M | $1.73M | $2.03M | $3.72M |
| Operating income | -$2.17M | -$2.70M | -$2.97M | -$3.44M | -$1.82M | -$1.56M | -$1.83M | -$3.94M |
| Interest expense | -$702 | $9,237 | $113,098 | $1.08M | $745,965 | $222,363 | $9,237 | -$379,628 |
| Pretax income | -$2.85M | -$3.10M | -$2.58M | -$7.80M | -$42,456 | -$1.90M | -$3.95M | -$4.47M |
| Income tax | $0 | -$17,899 | $23,738 | $50,437 | $0 | $1,728 | $13,505 | $1.15M |
| Net income | -$2.85M | -$1.74M | -$2.60M | -$7.85M | -$289,745 | -$2.61M | -$3.96M | -$5.62M |
| EBITDA | -$1.59M | -$2.06M | -$2.33M | -$2.79M | -$1.18M | -$908,468 | -$1.18M | -$3.27M |
| EPS (basic) | — | — | -0.05 | — | -0.02 | -0.16 | -0.24 | — |
| EPS (diluted) | — | — | -0.05 | — | -0.02 | -0.16 | -0.24 | — |
| Weighted avg. shares (diluted) | 734,931 | 53.66M | 47.90M | — | 206,867 | 16.42M | 16.31M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $41,666 | $454,151 | $1.35M | $5.05M | $472,759 | $291,595 | $410,122 | $326,115 |
| Receivables | $2.17M | $2.23M | $2.67M | $2.24M | $2.58M | $1.62M | $1.85M | $1.72M |
| Current assets | $2.82M | $3.27M | $4.84M | $8.37M | $3.72M | $2.56M | $3.08M | $3.02M |
| PP&E, net | $91,170 | $113,178 | $265,245 | $294,987 | $418,860 | $506,070 | $597,578 | $680,242 |
| Goodwill | $4.92M | $4.92M | $4.92M | $4.92M | $4.92M | $4.92M | $4.92M | $4.92M |
| Intangibles | $7.13M | $7.68M | $8.23M | $8.79M | $9.34M | $9.89M | $10.44M | $10.99M |
| Total assets | $15.71M | $16.73M | $19.02M | $22.41M | $18.71M | $18.21M | $19.40M | $19.99M |
| Current liabilities | $9.59M | $8.10M | $11.79M | $16.24M | $23.42M | $23.06M | $21.98M | $19.01M |
| Short-term debt | $125,758 | $334,582 | $524,093 | $880,175 | $1.94M | $1.46M | $1.09M | $433,983 |
| Long-term debt | $781,581 | $781,581 | $781,581 | $593,941 | $589,374 | $593,941 | $593,941 | $593,941 |
| Total debt | $907,339 | $1.12M | $1.31M | $1.47M | $2.53M | $2.05M | $1.68M | $1.03M |
| Total liabilities | $10.69M | $9.14M | $12.70M | $16.96M | $24.28M | $23.95M | $22.89M | $20.01M |
| Shareholders' equity | $5.01M | $7.59M | $6.32M | $5.45M | -$5.58M | -$5.74M | -$3.50M | -$18,488 |
| Net debt | $865,673 | $662,012 | -$40,458 | -$3.58M | $2.06M | $1.76M | $1.27M | $701,809 |
| Shares outstanding | 806,078 | 55.68M | 47.30M | 414,995 | 17.02M | 16.42M | 16.42M | 16.30M |
| Cash flow statement | ||||||||
| Operating cash flow | -$437,838 | -$1.17M | -$2.45M | -$1.93M | -$754,538 | -$324,601 | -$440,493 | -$2.97M |
| Capital expenditure | -$97,712 | $73,248 | $26,752 | $7,152 | $0 | $3,593 | $11,873 | $4,760 |
| Free cash flow | -$340,126 | -$1.25M | -$2.48M | -$1.93M | -$754,538 | -$328,194 | -$452,366 | -$2.98M |
| Investing cash flow | -$56,823 | -$2,000 | -$126,752 | -$7,152 | -$7,310 | -$3,593 | -$11,873 | -$4,760 |
| Financing cash flow | $82,176 | $498,585 | -$1.34M | $6.73M | $943,012 | $209,667 | $536,373 | $977,832 |
| Depreciation & amortization | $576,795 | $640,185 | $646,619 | $653,792 | $644,017 | $647,599 | $647,037 | $671,706 |
| Stock-based compensation | $0 | $202,555 | $441,306 | $360,483 | $0 | $371,930 | $392,106 | $515,453 |
| Share buybacks | -$50,000 | $0 | $50,000 | $0 | $0 | $44 | $0 | $5,150 |
Free plan shows the latest 8 periods; Pro shows all 21 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.